CSF2 and cancer: Also, it was shown that Apigenin is able to block tumor necrosis factor-alpha (TNFα) pathway in MDA- MB231 cancer cells; therefore, the following release of chemokines such as CCL2, granulocyte-macrophage colony-stimulating factor (GMCSF), IL-1α and IL-6 is inhibited.